Global economic burden of schizophrenia: response to authors’ reply
Amanda L Neil,1 Vaughan J Carr2,3 1Menzies Institute for Medical Research, The University of Tasmania, Hobart, TAS, 2Research Unit for Schizophrenia Epidemiology, University of New South Wales, Sydney, NSW, 3Department of Psychiatry, School of Clinical Sciences, Monash University, Melbourne, VIC, A...
Main Authors: | Neil AL, Carr VJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/global-economic-burden-of-schizophrenia-response-to-authorsrs-reply-peer-reviewed-article-NDT |
Similar Items
-
Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites
by: Saehyeon Kim, et al.
Published: (2022-03-01) -
Interventions for adolescents and adults with psychosis in Africa: a systematic review and narrative synthesis
by: Xanthe Hunt, et al.
Published: (2022-01-01) -
The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis
by: Ahmad Faramarzi, et al.
Published: (2024-02-01) -
A systematic review of Clinical Practice Guidelines for the development of the WHO's Package of Interventions for Rehabilitation: focus on schizophrenia
by: Riccardo Serra, et al.
Published: (2023-08-01) -
Implications of the COVID-19 pandemic for patients with schizophrenia spectrum disorders: narrative review
by: Naista Zhand, et al.
Published: (2021-01-01)